Park Medi World Ltd
Park Medi World Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Conservative revenue and EBITDA growth forecast of about 7.5%, despite a 12-15% government rate hike, reflecting cautious accounting. Park Medi World's EBITDA margin is expected to remain stable around 26%-27% over the mid to long term (3-10 years).
From Park Medi World Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Conservative revenue and EBITDA growth forecast of about 7.5%, despite a 12-15% government rate hike, reflecting cautious accounting.
- Significant bed capacity expansion planned: from 3,250 beds in FY26 to approximately 5,260 beds by FY28, indicating strong volume growth.
- Entry and cluster expansion in Uttar Pradesh with 1,060 beds expected by FY28, covering Agra, Kanpur, Gorakhpur, leveraging the large 260+ million population for market capture.
- FY26 capex of ~INR 280 crores for Agra and Panchkula units; FY27 capex primarily for Kanpur and Delhi (~INR 110 crores).
- Expect consistent EBITDA margins of 26-27% and PAT margins of 15-17% over the next 3-10 years, indicating stable profitability alongside volume growth.
2 more points from Park Medi World Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Park Medi World Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY 2026: Total capex of about INR 280 crores, including:
- INR 245 crores for Agra acquisition (360 beds)
- INR 35 crores for ongoing construction at Panchkula (greenfield, 300 beds), operational by March 2026
- FY 2027: Capex of INR 110 crores anticipated for adding 500 beds across Kanpur (INR 30 crores) and Delhi (INR 80 crores)
- FY 2028: Adding three hospitals in Gorakhpur, Ambala, Rohtak; total 850 beds
- Overall by March 2028: Adding approximately 2,010 beds on a capex of INR 700 crores, maintaining a capex per bed around INR 35 lakhs
- Strategy focuses on both brownfield acquisitions (distressed assets with growth headroom) and greenfield expansions
2 more points from Park Medi World Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Park Medi World Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Park Medi World Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Park Medi World Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹460 Cr, net profit ₹77 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Park Medi World Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Vijaya Diagnostic Centre Ltd (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
- Chandan Healthcare Ltd (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
- Rainbow Childrens Medicare Ltd (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…
- Krsnaa Diagnostics Ltd (Q3 FY26)
Retail segment showing strong momentum, with retail revenue growing nearly 8x YoY in Q3 FY '26, contributing 8% of total revenue; network expanded to over…
Arthneeti Pro · Annual
Park Medi World Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Park Medi World Ltd Q3 FY26 results?
Conservative revenue and EBITDA growth forecast of about 7.5%, despite a 12-15% government rate hike, reflecting cautious accounting. Park Medi World's EBITDA margin is expected to remain stable around 26%-27% over the mid to long term (3-10 years).
What is Park Medi World Ltd share price analysis?
Park Medi World Ltd currently shows a neutral. The stock trades at a P/E of 44.3 with a market cap of ₹12,304 Cr. Investors should review the full earnings analysis for detailed insights.
Is Park Medi World Ltd planning capital expenditure?
FY 2026: Total capex of about INR 280 crores, including: - INR 245 crores for Agra acquisition (360 beds) - INR 35 crores for ongoing construction at Panchkula (greenfield, 300 beds), operational by March 2026 - FY 2027: Capex of INR 110 crores anticipated for adding 500 beds across Kanpur (INR 30 crores) and Delhi (INR 80 crores) - FY 2028: Adding three hospitals in Gorakhpur, Ambala, Rohtak; total 850 beds - Overall by March 2028: Adding approximately 2,010 beds on a capex of INR 700 crores, maintaining a capex per bed around INR 35 lakhs - Strategy focuses on both brownfield acquisitions (distressed assets with growth headroom) and greenfield expansions - Capex per bed varies by project; e.g., Agra at approx.
Keep Park Medi World Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.